NCT07209449 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07209449
Title	A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Recruitment	Recruiting
Gender	female
Phase	Phase II
Variant Requirements	Yes
Sponsors	Memorial Sloan Kettering Cancer Center
Indications	endometrial mixed adenocarcinoma endometrial squamous cell carcinoma endometrial mucinous adenocarcinoma endometrial carcinoma endometrial transitional cell carcinoma endometrial serous adenocarcinoma endometrial clear cell adenocarcinoma
Therapies	Elacestrant Abemaciclib + Elacestrant
Age Groups:	adult \| senior
Covered Countries	USA

NCT07209449
Clinical Trial Detail